Amgen Archives - Pharmaphorum

Mundipharma’s Neulasta biosimilar approved in EU

https://pharmaphorum.com/news/mundipharmas-neulasta-biosimilar-approved-in-eu/

Lilly files new class migraine drug with FDA

https://pharmaphorum.com/news/lilly-files-new-class-migraine-drug-with-fda/

Amgen cuts US price of cholesterol drug by 60%

https://pharmaphorum.com/news/amgen-cuts-us-price-of-cholesterol-drug-by-60/

Teva slumps after Express Scripts funds migraine rivals in US

https://pharmaphorum.com/news/teva-slumps-after-express-scripts-funds-migraine-rivals-in-us/

Lilly pushes into migraine market as Emgality approved in US

https://pharmaphorum.com/news/lilly-pushes-into-migraine-market-as-emgality-approved-in-us/

FDA approves Teva’s migraine drug, decision due on Lilly’s rival

https://pharmaphorum.com/news/fda-approves-tevas-migraine-drug-decision-due-on-lillys-rival/

Balancing the sySTEM

https://pharmaphorum.com/r-d/views-analysis-r-d/balancing-the-system/

Amgen/AZ’s phase 3 asthma biologic could get fast review

https://pharmaphorum.com/news/amgen-azs-phase-3-asthma-biologic-could-get-fast-review/

Breakthrough designation AstraZeneca’s severe asthma drug

https://pharmaphorum.com/news/astrazeneca-asthma-breakthrough/

Search